WHAMM Inhibits Type II Alveolar Epithelial Cell EMT by Mediating Autophagic Degradation of TGF‐β1 in Bronchopulmonary Dysplasia
Journal of Cellular Physiology · 2025
DOI: 10.1002/jcp.31486 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular Physiology, 2025. Verfasst von Shaodong Hua und 9 weiteren Autor:innen. Beteiligte Einrichtung: General Internal Medicine, Senior Department of Pediatrics, the Seventh Medical Center of PLA General Hospital, Beijing, China. Hauptthemen laut MEDLINE: Bronchopulmonary Dysplasia, Autophagy, Transforming Growth Factor beta1, Epithelial-Mesenchymal Transition. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: This study was supported by the National Key Research and Development Program of China (No. 2021YFC2701701)..
Abstract (Originalsprache)
Bronchopulmonary dysplasia (BPD) is one of the most prevalent complication in preterm infants, primarily characterized by arrested alveolar growth. The involvement of epithelial–mesenchymal transition (EMT) of AECII cells is proposed to have a crucial role in the pathogenesis of BPD; however, the underlying mechanism remains unclear. The present study reveals a significant reduction of WHAMM (WASP homolog associated with actin, membranes, and microtubules) in hyperoxia‐induced BPD mice, highlighting its crucial role in suppressing the progression of BPD through the inhibition of EMT in AECIIs. We demonstrated that hyperoxia‐induced downregulation of WHAMM leads to the accumulation of TGF‐β1 primarily through its mediation of the autophagic degradation pathway. Mechanistically, WHAMM enhanced the autophagosomal localization of TGF‐β1 and concurrently promoted the process of autophagy, thereby comprehensively facilitating the autophagic degradation of TGF‐β1. These findings reveal the important role of WHAMM in the development of BPD, and the proposed WHAMM/autophagy/TGF‐β1/EMT pathway may represent a potential therapeutic strategy for BPD treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- General Internal Medicine, Senior Department of Pediatrics, the Seventh Medical Center of PLA General Hospital, Beijing, China.
- Department of Pediatrics, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China.
ORCID-Profile: Shaodong Hua
Förderung
- This study was supported by the National Key Research and Development Program of China (No. 2021YFC2701701).
Zitieren
APA
Hua, S., Chi, J., Zhang, N., Yang, X., Zhang, P., Jiang, C., Feng, Y., Hong, X., Feng, Z., & Yan, Y. (2025). WHAMM Inhibits Type II Alveolar Epithelial Cell EMT by Mediating Autophagic Degradation of TGF‐β1 in Bronchopulmonary Dysplasia. Journal of Cellular Physiology. https://doi.org/10.1002/jcp.31486
Vancouver
Hua S, Chi J, Zhang N, Yang X, Zhang P, Jiang C, et al. WHAMM Inhibits Type II Alveolar Epithelial Cell EMT by Mediating Autophagic Degradation of TGF‐β1 in Bronchopulmonary Dysplasia. Journal of Cellular Physiology. 2025. doi:10.1002/jcp.31486
BibTeX
@article{Hua2025,
author = {Hua, Shaodong and Chi, Jinghan and Zhang, Ning and Yang, Xiao and Zhang, Pan and Jiang, Chenyang and Feng, Yao and Hong, Xiaoyang and Feng, Zhichun and Yan, Yurou},
title = {WHAMM Inhibits Type II Alveolar Epithelial Cell EMT by Mediating Autophagic Degradation of TGF‐β1 in Bronchopulmonary Dysplasia},
journal = {Journal of Cellular Physiology},
year = {2025},
doi = {10.1002/jcp.31486}
}
EUVIMED